Skip links and keyboard navigation

PAH-QEII Network

3D Avatar for Skin Cancer Research

| PAH-QEII Network

The Princess Alexandra Hospital is now home to Australia’s first 3D Avatar – a revolutionary skin cancer-detecting system.

Status: 

Breast cancer technology protecting the heart

| PAH-QEII Network

New Technology at Princess Alexandra Hospital used in the treatment of breast cancer is protecting the heart from radiation doses used to treat cancer.

Status: 

Management of Delirium in Hospital: Development of a Metro South Occupational Therapy Learning Package

| PAH-QEII Network

This project aimed to develop an OT Delirium Management Learning Package, to be implemented in hospital Occupational Therapy departments across the Metro South Health and Hospital Service. 

Status: 

Personalising treatment for cancer patients with Australia's first PET-MRI technology

| PAH-QEII Network

PA Hospital commenced scanning with the first clinical PET-MRI in Australia in December 2014 and has already completed more clinical studies in its first six months using this amazing technology th

Status: 

Queensland’s newest and most advanced CT scanner

| PAH-QEII Network

Princess Alexandra Hospital (PAH) is home to Queensland’s newest and most advanced CT scanner that is setting new standards in speed and dose reduction for patients.

Status: 

ScreenIT - revolutionary app solution for head and neck cancer patients

| PAH-QEII Network

Princess Alexandra Hospital (PAH) has found a screening App could improve the clinical management of head and neck cancer patients, providing an efficient and effective alternative to additional cl

Status: 

World's smallest leadless pacemaker

| PAH-QEII Network

Heart patients at Princess Alexandra Hospital are receiving the benefits of the world’s smallest pacemaker, which is just one-tenth of the size of a traditional device and doesn’t require leads.

Status: 

World-first spinal cord injury trial at PAH

| PAH-QEII Network

Princess Alexandra Hospital (PAH) researchers are launching a world-first clinical trial aimed at improving recovery from spinal cord injuries.

Status: